Expertise and rankings

Pancreas transplant teamwork at Mayo Clinic Pancreas transplant teamwork at Mayo Clinic


Mayo Clinic has one of the largest transplant practices in the United States. Across its three sites in Minnesota, Florida and Arizona, Mayo Clinic has performed hundreds of successful pancreas transplants, averaging more than 50 pancreas transplants each year.

Mayo Clinic is one of only a few transplant centers that offers pancreas transplants to select candidates with type 2 diabetes and treated HIV.

Pancreas transplant outcomes at Mayo Clinic compare favorably with the national average.

Innovation and research

Mayo Clinic surgeons have extensive expertise in many areas of pancreas transplantation, including pancreas-only, simultaneous pancreas-kidney and pancreas-after-kidney transplant.

The Mayo Clinic Transplant Center supports many studies and for pancreas transplant research. Mayo Clinic doctors actively research pancreas transplantation techniques and treatment options, presenting their work at national and international meetings.

For example, researchers at Mayo Clinic are developing an artificial pancreas that could significantly improve the quality of life for people with type 1 diabetes and potentially provide an alternative to pancreas transplant.

Artificial Pancreas Lab at Mayo Clinic. Artificial Pancreas Lab

Mayo Clinic researchers are also investigating ways to lower the rejection risk among transplant recipients and seeking new ways to treat people who need transplants of all types.

Watch Mark Stegall, M.D., and Richard Daly, M.D., discuss lowering rejection risk in organ transplants.

Nationally recognized expertise

Mayo Clinic in Rochester, Minn., ranks No. 1 for diabetes and endocrinology in the U.S. News & World Report Best Hospitals rankings. Mayo Clinic in Scottsdale, Ariz., is ranked among the Best Hospitals for diabetes and endocrinology by U.S. News & World Report.

Read more about the Pancreas Transplant Program at Mayo Clinic.

June 24, 2016
  1. Klein CL, et al. Patient selection for and immunologic issues relating to kidney-pancreas transplantation in diabetes mellitus. Accessed March 21, 2016.
  2. Klein C, et al. Benefits and complications associated with kidney-pancreas transplantation in diabetes mellitus. Accessed March 21, 2016.
  3. Pancreas transplantation. American Diabetes Association. Accessed March 21, 2016.
  4. Robertson RP. Pancreas and islet transplantation in diabetes mellitus. Accessed March 21, 2016.
  5. Health after transplantation. American Society of Transplantation. Accessed March 22, 2016.
  6. Preparing for the transplant. American Society of Transplantation. Accessed March 22, 2016.
  7. Kidney-pancreas transplant. National Kidney Foundation. Accessed March 22, 2016.
  8. Scientific Registry of Transplant Recipients 2012 Annual Data Report: Pancreas. Health Resources and Services Administration. Accessed April 12, 2016.
  9. Chakkera HA (expert opinion). Mayo Clinic, Phoenix, Arizona. April 12, 2016.
  10. Side effects. UNOS Transplant Living. Accessed March 22, 2016.
  11. Pancreas transplant. National Kidney Foundation. Accessed March 22, 2016.
  12. Heilman RL, et al. Immunosuppression in simultaneous pancreas-kidney transplantation. Drugs. 2010;70:793.
  13. Kandaswamy R, et al. Pancreas. American Journal of Transplantation. 2016;16(suppl 2):47.
  14. Pancreas. Organ Procurement and Transplantation Network. Accessed March 23, 2016.
  15. Barbara Woodward Lips Patient Education Center. Pancreas transplant. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2013.
  16. Pancreas. PubMed Health. Accessed April 7, 2016.
  17. Guidance for industry: Considerations for allogeneic pancreatic islet cell products. U.S. Food and Drug Administration. Accessed March 28, 2016.
  18. Pancreatic islet transplantation. National Institute of Diabetes and Digestive and Kidney Diseases. Accessed March 28, 2016.
  19. Kudva YC, et al. Comprehensive immune monitoring reveals profound immunological changes in pancreas after kidney (PAK) transplant recipients. Human Immunology. 2013;74:738.
  20. Reddy KS, et al. Alemtuzumab with rapid steroid taper in simultaneous kidney and pancreas transplantation: Comparison to induction with antithymocyte globulin. Transplantation Proceedings. 2010;42:2006.
  21. Riggin ER. Allscripts EPSi. Mayo Clinic, Rochester, Minn. April 6, 2016.